Physician
Oncology
Dr. James A. Knost, MD
|
|
Give Review
James A. Knost practices Oncology. He studied medicine at Louisiana State University School of Medicine in New Orleans. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". James Knost is also a published doctor. He has 33 paper published. The most recent paper is: Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovo... He is registered with Medicare and accepts Medicare payments.
Publications
- Dasatinib in previously treated metastatic colorectal Cancer: a phase II trial of the University of Chicago Phase II Consortium.
- Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal Cancer and gastroesophageal junction tumors.
- A phase II study of sorafenib in advanced uterine Carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.
- Frequent loss of cystatin E/M expression implicated in the progression of prostate Cancer.
- Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate Cancer cells to genotoxic stress.
- A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal Cell carcinoma.
- Oxaliplatin and capecitabine in patients with metastatic adenoCarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North...
- Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
- Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
- Long-term survival of patients with advanced/recurrent Carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisp...
- Comparison of lymphoid neoplasm classification. A blinded study between a community and an academic setting.
- Utility of flow cytometry immunophenotyping for the diagnosis and classification of Lymphoma in community hospital clinical needle aspiration/biopsies.
- A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma.
- A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung Cancer.
- Evaluation of soy phytoestrogens for the treatment of hot flashes in breast Cancer survivors: A North Central Cancer Treatment Group Trial.
- Utility of flow cytometry in subtyping composite and sequential Lymphoma.
- Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovo...
- Phase II trial of irinotecan in patients with metastatic coloRectal carcinoma.
- Monoclonal antibodies to human coloRectal tumor-associated antigens: improved elicitation and subclass restriction.
- Determination of the optimal human Cell lines for development of human hybridomas.
- Combination of vindesine and prednisone in malignant lymphoma and Acute leukemia.
- Recombinant leukocyte A interferon in advanced breast Cancer. Results of a phase II efficacy trial.
- The treatment of Cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.
- A multiple-dose phase I trial of recombinant leukocyte A interferon in Cancer patients.
- Phase II study of vindesine in patients with advanced breast Cancer.
- Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
- Increased steroid dependence after recombinant leucocyte interferon therapy.
- Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung Cancer.
- Combination of vinblastine and bleomycin in metastatic renal Cell carcinoma.
- Limited stage small cell lung Cancer.
- Penetrating abdominal injuries in children and adolescents.
- Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal Cancer: minimal activity in colorectal Cancer.
Schools
Louisiana State Univ School Of Medicine In New Orleans
Vanderbilt University Med Center
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Choice Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance PPO
- Medicare Advantage PFFS
- HealthLink PPO
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- NGS CoreSource
- Pekin Insurance
- Pipefitters
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Vanderbilt University -
Louisiana State University School of Medicine in New Orleans
Drug Facts
| NPI NUMBER | 1245239565 | |
| NPPES Provider LastName | KNOST | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 616157822 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1599.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 308.0 | |
| Percent Opioid Claims | 19.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245239565 |
| Last Name Of The Provider | KNOST |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Sumita Bhatta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Gerstner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan N. Upalakalin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Srinivas Jujjavarapu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen A. Cullinan, MD
This Doctor is OpenDoctor Recommended.
|